ACADIA Pharmaceuticals (ACAD) News Today

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

$17.07

-0.12 (-0.70%)

(As of 04/18/2024 ET)

Source

Source	Headline
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 52-Week Low at $16.60 americanbankingnews.com - April 18 at 4:50 AM
	Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting businesswire.com - April 17 at 4:05 PM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 52-Week Low at $16.60 marketbeat.com - April 16 at 11:02 AM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Up 5.4% in March americanbankingnews.com - April 16 at 4:44 AM
	Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Acadia Healthcare (ACHC) and Coherus Biosciences (CHRS) markets.businessinsider.com - April 15 at 8:57 AM
	Brokers Issue Forecasts for ACADIA Pharmaceuticals Inc.'s FY2026 Earnings (NASDAQ:ACAD) americanbankingnews.com - April 13 at 3:22 AM
	3 Affordable Pharma Stocks to Buy for Portfolio Gains stocknews.com - April 12 at 1:00 PM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Post FY2026 Earnings of $1.42 Per Share, Leerink Partnrs Forecasts marketbeat.com - April 12 at 6:56 AM
	Leerink Partnrs Analysts Cut Earnings Estimates for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) americanbankingnews.com - April 12 at 2:08 AM
	Acadia Pharmaceuticals executive sells over $31,000 in company stock investing.com - April 11 at 11:18 PM
	Acadia Pharmaceuticals exec sells over $45k in stock investing.com - April 11 at 11:18 PM
	3 Pharma Stocks to Sell in April Before They Crash & Burn investorplace.com - April 11 at 2:10 PM
	Buy Rating Justified by Vertex Pharmaceuticals’ Strategic Acquisitions and Promising Drug Pipeline markets.businessinsider.com - April 11 at 1:17 PM
	ACADIA Pharmaceuticals Inc. to Post Q2 2024 Earnings of $0.17 Per Share, Leerink Partnrs Forecasts (NASDAQ:ACAD) marketbeat.com - April 11 at 7:11 AM
	ACADIA Pharmaceuticals' (ACAD) Overweight Rating Reiterated at Cantor Fitzgerald americanbankingnews.com - April 11 at 4:40 AM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 12-Month Low Following Insider Selling americanbankingnews.com - April 11 at 1:04 AM
	Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals markets.businessinsider.com - April 10 at 5:01 PM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Earns "Overweight" Rating from Cantor Fitzgerald marketbeat.com - April 10 at 10:25 AM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 52-Week Low After Insider Selling marketbeat.com - April 10 at 10:24 AM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CFO Mark C. Schneyer Sells 2,716 Shares americanbankingnews.com - April 10 at 7:18 AM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Insider James Kihara Sells 1,790 Shares insidertrades.com - April 10 at 6:10 AM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) COO Brendan Teehan Sells 2,568 Shares americanbankingnews.com - April 10 at 6:10 AM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis Sells 26,574 Shares americanbankingnews.com - April 10 at 5:12 AM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Buy Rating from Needham & Company LLC americanbankingnews.com - April 10 at 4:24 AM
	James Kihara Sells 1,790 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock marketbeat.com - April 9 at 6:31 PM
	Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Recursion Pharmaceuticals (RXRX) markets.businessinsider.com - April 9 at 10:57 AM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Rating Reaffirmed by Needham & Company LLC marketbeat.com - April 9 at 8:30 AM
	Acadia Pharmaceuticals names new EVP of Research and Development investing.com - April 4 at 4:40 PM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Average Recommendation of "Moderate Buy" by Analysts marketbeat.com - April 2 at 4:22 AM
	Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference finance.yahoo.com - April 1 at 6:26 PM
	Buy Rating Affirmed for Syros Pharmaceuticals Amid Promising Clinical Trials and Strategic Study Designs markets.businessinsider.com - April 1 at 1:26 PM
	Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) COO Sells 5,140 Shares of Stock insidertrades.com - March 29 at 6:44 AM
	Vanguard Group Inc. Decreases Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) marketbeat.com - March 29 at 4:18 AM
	These Overlooked Mid-Cap Gems Are Ripe for a Rebound uk.investing.com - March 28 at 9:39 AM
	ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 17,714 Shares finance.yahoo.com - March 28 at 9:39 AM
	ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) COO Brendan Teehan Sells 5,140 Shares marketbeat.com - March 27 at 9:29 PM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 1-Year Low on Analyst Downgrade marketbeat.com - March 25 at 2:42 PM
	ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Cut to $25.00 marketbeat.com - March 25 at 12:17 PM
	Analysts Are Bullish on Top Healthcare Stocks: Immatics (IMTX), Vor Biopharma (VOR) markets.businessinsider.com - March 25 at 3:22 AM
	FY2024 EPS Estimates for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Reduced by Zacks Research marketbeat.com - March 21 at 7:45 AM
	4 Cutting-Edge Pharma Stocks for Portfolio Diversification stocknews.com - March 19 at 7:01 PM
	Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Edwards Lifesciences (EW) and Aveanna Healthcare Holdings (AVAH) markets.businessinsider.com - March 18 at 1:54 PM
	Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) businesswire.com - March 15 at 4:05 PM
	3 Pharma Stocks to Sell in March Before They Crash & Burn investorplace.com - March 14 at 6:49 PM
	Grabar Law Office Investigates Claims on Behalf of Shareholders of Acadia Pharmaceuticals Inc. (ACAD) markets.businessinsider.com - March 13 at 11:05 PM
	Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day finance.yahoo.com - March 13 at 6:04 PM
	Evaluating Acadia's Market Position Following Pimavanserin's Clinical Setback seekingalpha.com - March 13 at 9:23 AM
	ACADIA Pharmaceuticals Sinks After Schizophrenia Drug Failed In Late-stage Study markets.businessinsider.com - March 13 at 1:48 AM
	These Stocks Are Moving the Most Today: Oracle, Acadia Pharmaceuticals, Vail Resorts, and More msn.com - March 13 at 1:48 AM
	Acadia drug fails schizophrenia trial, setting back company’s expansion plans finance.yahoo.com - March 12 at 3:47 PM

Get ACADIA Pharmaceuticals News Delivered to You Automatically

Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ACAD Media Mentions By Week

ACAD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACAD
News Sentiment
▼
-0.18

0.53
▲
Average
Medical
News Sentiment

ACAD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACAD Articles
This Week
▼
13

6
▲
ACAD Articles
Average Week

Get ACADIA Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ACAD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ACADIA Pharmaceuticals (ACAD) News Today

ACAD Media Mentions By Week

ACAD Media Sentiment

ACAD News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info